safinamide has been researched along with corticosterone in 1 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (corticosterone) | Trials (corticosterone) | Recent Studies (post-2010) (corticosterone) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 27,121 | 124 | 6,622 |
| Protein | Taxonomy | safinamide (IC50) | corticosterone (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 3 | Homo sapiens (human) | 0.945 | |
| Solute carrier family 22 member 3 | Rattus norvegicus (Norway rat) | 4.9 | |
| Solute carrier family 22 member 2 | Rattus norvegicus (Norway rat) | 4.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaro, S; Bagetta, D; Borges, F; Cagide, F; Oliveira, PJ; Ortuso, F; Pérez, C; Reis, J; Rodríguez-Franco, MI; Teixeira, J; Uriarte, E; Valencia, ME | 1 |
1 other study(ies) available for safinamide and corticosterone
| Article | Year |
|---|---|
Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors.
Topics: Alzheimer Disease; Blood-Brain Barrier; Cholinesterase Inhibitors; Cholinesterases; Chromones; Drug Design; Hep G2 Cells; Humans; Ligands; Molecular Docking Simulation; Molecular Targeted Therapy; Monoamine Oxidase; Monoamine Oxidase Inhibitors | 2018 |